| American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri, C Blair, K Dane, ... Blood advances 5 (3), 872-888, 2021 | 437 | 2021 |
| The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis PS Kolb, EA Ayaub, W Zhou, V Yum, JG Dickhout, K Ask The international journal of biochemistry & cell biology 61, 45-52, 2015 | 251 | 2015 |
| GRP78 and CHOP modulate macrophage apoptosis and the development of bleomycin‐induced pulmonary fibrosis EA Ayaub, PS Kolb, Z Mohammed‐Ali, V Tat, J Murphy, PS Bellaye, ... The Journal of pathology 239 (4), 411-425, 2016 | 117 | 2016 |
| Functional characterization of patients with chronic thromboembolic disease M Held, P Kolb, M Grün, B Jany, G Hübner, A Grgic, R Holl, HJ Schaefers, ... Respiration 91 (6), 503-509, 2016 | 112 | 2016 |
| The importance of interventional timing in the bleomycin model of pulmonary fibrosis P Kolb, C Upagupta, M Vierhout, E Ayaub, PS Bellaye, J Gauldie, ... European Respiratory Journal 55 (6), 2020 | 106 | 2020 |
| A symptom-related monitoring program following pulmonary embolism for the early detection of CTEPH: a prospective observational registry study M Held, A Hesse, F Gött, R Holl, G Hübner, P Kolb, HJ Langen, T Romen, ... BMC pulmonary medicine 14, 1-8, 2014 | 64 | 2014 |
| Anxiety, depression, and health-related QOL in patients diagnosed with PAH or CTEPH E Pfeuffer, H Krannich, M Halank, H Wilkens, P Kolb, B Jany, M Held Lung 195, 759-768, 2017 | 44 | 2017 |
| IL‐6 mediates ER expansion during hyperpolarization of alternatively activated macrophages EA Ayaub, K Tandon, M Padwal, J Imani, H Patel, A Dubey, O Mekhael, ... Immunology and Cell Biology 97 (2), 203-217, 2019 | 23 | 2019 |
| FK506-binding protein 13 expression is upregulated in interstitial lung disease and correlated with clinical severity. A potentially protective role V Tat, EA Ayaub, A Ayoub, M Vierhout, S Naiel, MK Padwal, S Abed, ... American Journal of Respiratory Cell and Molecular Biology 64 (2), 235-246, 2021 | 11 | 2021 |
| Idiopathic Pulmonary Fibrosis C Shimbori, PS Bellaye, P Kolb, M Kolb Treatment of Cystic Fibrosis and Other Rare Lung Diseases, 39-69, 2017 | 1 | 2017 |
| C64 HAVING A BLAST WITH FIBROBLASTS: Ire1 Mediated Xbp1 Splicing Is Critical For Pulmonary Fibroblast Proliferation And Differentiation J Murphy, PS Kolb, E Ayaub, S Mahmood, S Naiel, M Gravina, ... American journal of respiratory and critical care medicine 191, 1, 2015 | 1 | 2015 |
| Il-6 Mediated Hyperpolarization Of Profibrotic Macrophages Is Dependent On Spliced Xbp1 E Ayaub, K Tandon, P Parthasarathy, J Murphy, PS Kolb, S Lhotak, ... D27. MACROPHAGES: RESOLVERS, RESPONDERS OR BOTH?, A6602-A6602, 2016 | | 2016 |
| The Value Of A Systematic Assessment Of Medication Use And Polypharmacy In Patients With Ipf S Maharaj, PS Kolb, N Hambly, G Cox, MRJ Kolb C102. STATEGIES TO UNDERSTAND ILD: REGISTRIES, PROGNOSTIC INDICATORS AND …, 2016 | | 2016 |
| How Basic Science Methodology Has Changed In The Context Of The Bleomycin Model Of Pulmonary Fibrosis PS Kolb, D Miller, J Lee, C Shimbori, PS Bellaye, K Ask, MRJ Kolb B62. THE BIOLOGY OF SCARRING. WHERE ARE WE NOW, A4175-A4175, 2016 | | 2016 |
| Fkbp13 Deficiency Leads To Increased Pulmonary Er Stress, Inflammation And Fibrosis After Bleomycin Administration E Ayaub, A Bhargava, J Murphy, P Kolb, S Lothak, C Richards, MRJ Kolb, ... D96. WHY SO STRESSED? ENDOPLASMIC RETICULUM, PROTEIN FOLDING, AND OXIDATION …, 2014 | | 2014 |
